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Mammalian splicing divergence is shaped by drift,
buffering in trans, and a scaling law
Xudong Zou1,2,* , Bernhard Schaefke1,2,3,* , Yisheng Li2, Fujian Jia2, Wei Sun2, Guipeng Li1,2,3, Weizheng Liang2,
Tristan Reif4, Florian Heyd4, Qingsong Gao5, Shuye Tian1,2, Yanping Li2, Yisen Tang2, Liang Fang1,2,3 , Yuhui Hu1,2 ,
Wei Chen1,2,3
Alternative splicing is ubiquitous, but the mechanisms underlying
its pattern of evolutionary divergence across mammalian tissues
are still underexplored. Here, we investigated the cis-regulatory
divergences and their relationship with tissue-dependent trans-
regulation in multiple tissues of an F1 hybrid between two mouse
species. Large splicing changes between tissues are highly con-
served and likely reflect functional tissue-dependent regulation.
In particular, micro-exons frequently exhibit this pattern with
high inclusion levels in the brain. Cis-divergence of splicing
appears to be largely non-adaptive. Although divergence is in
general associated with higher densities of sequence variants in
regulatory regions, events with high usage of the dominant
isoform apparently toleratemoremutations, explaining why their
exon sequences are highly conserved but their intronic splicing
site flanking regions are not. Moreover, we demonstrate that non-
adaptive mutations are often masked in tissues where accurate
splicing likely is more important, and experimentally attribute
such buffering effect to trans-regulatory splicing efficiency.
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Introduction
Splicing is an important gene regulatory step in multicellular eu-
karyotes. Often the same pre-mRNA transcript can be spliced in
various ways (Berget et al, 1977; Chow et al, 1977), leading to different
combinations of exons in the mature transcript. This so-called
alternative splicing (AS) contributes to the variety of the cellular
transcriptome/proteome as well as to the fine tuning of gene
expression on the post-transcriptional level (Nilsen & Graveley,
2010; Kelemen et al, 2013).
Individual examples for important biological roles of AS have
been extensively documented (Braunschweig et al, 2013; Kelemen
et al, 2013; Raj & Blencowe, 2015; Baralle & Giudice, 2017), and
several studies suggest that large changes in relative isoform
abundance between tissues are functionally relevant (Wang et al,
2008; Reyes et al, 2013; Tapial et al, 2017). In particular, a special class
of exon which is 3–30 nucleotides in length, called micro-exon, is
abundantly regulated in the nervous system and plays a neural-
specific function (Irimia et al, 2014; Li et al, 2015). Nevertheless, it has
been proposed that to a certain degree AS between organs or cell
types can be explained as splicing noise because only a small
percentage of isoforms detected on the transcript level has been
confirmed on the protein level (Abascal et al, 2015; Tress et al, 2017a,
2017b), and the role of AS and nonsense-mediated decay in reg-
ulating gene expression levels appears to be limited (Saudemont et
al, 2017). Recent studies on alternative polyadenylation (Xu &
Zhang, 2018), alternative transcriptional initiation (Xu et al, 2019),
and stop-codon read-through (Li & Zhang, 2019) by the Zhang
laboratory documented that generally lowly expressed genes ex-
hibit more variation in these molecular phenotypes, supporting the
“error hypothesis,” that is, each gene has one optimal transcript
isoform and alternative isoforms arise primarily from imprecise
molecular processing rather than functional regulation.
A related question is the contribution of changes in AS to
adaptive divergence between species. The neutral theory of mo-
lecular evolution states that most of the observed sequence
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variation within and between species is selectively neutral (Kimura,
1979, 1989). Purifying selection and random drift are the major
forces determining the fate of new mutations, with positive se-
lection only playing a minor role. The neutral model has been
widely accepted as the null hypothesis in studies of sequence
evolution, and the approach has been extended to molecular
phenotypes and cellular morphology (Ho et al, 2017; Xu & Zhang,
2018; Zhang, 2018). In comparison to tissue-dependent mRNA ex-
pression levels, AS patterns generally diverge more rapidly in
vertebrates (Barbosa-Morais et al, 2012; Merkin et al, 2012; Schaefke
et al, 2018), and numerous variants within humans have been found
to affect splicing patterns across tissues (Amoah et al, 2021).
Whereas evolutionary divergence of AS between closely related
mammalian species can be largely attributed to cis-regulatory
changes (Gao et al, 2015), the global significance of these changes
and their mechanistic relationship with tissue-dependent trans-
regulation remain undetermined.
To investigate tissue-dependent AS and its role in gene regu-
latory divergence in mammals, we use an F1 hybrid between two
mouse species (C57BL/6J, a laboratory strain largely derived from
the Mus musculus domesticus subspecies [Bonhomme et al, 2008],
and SPRET/EiJ, a wild-derived inbred Mus spretus strain [Dejager
et al, 2009]). Using high-throughput RNA-seq, we investigate the cis-
regulatory component of AS divergence between the two strains
across six organs and embryonic stem cells (ESC). We examine the
effects of AS on coding sequences (CDS) and compare the splicing
patterns of different genes with various gene expression levels and
evolutionary conservation. Our results suggest that the general
patterns of cis-regulatory divergence between the two species
largely conform to the neutral hypothesis of molecular evolution. But
in many cases non-adaptive cis-regulatory changes in AS only be-
come visible in tissues where accurate splicing likely is of lesser
importance, whereas they appear to be buffered in tissues where the
gene is highly expressed. To test the role of the trans-regulatory
splicing machinery in this buffering, we chemically perturbed the
spliceosome in F1 hybrid fibroblasts. Indeed, the magnitude of allelic
divergence increased, and the effects of previously buffered cis-
regulatory mutations became unveiled after splicing perturbation.
In addition, we find that the magnitude of allelic splicing di-
vergence is not only dependent on the number of variants in
regulatory regions, but that a cis-regulatory mutation could lead to
a change of greater magnitude for an event with intermediate
inclusion levels than for one with either very high or very low
inclusion levels. This finding is in accordance with a recent study
describing a scaling law based on the kinetics of competition
between splice sites (Baeza-Centurion et al, 2019), showing the
large-scale effect of this mechanism on AS divergence.
Results
AS diversity within and across tissues reflects both molecular
error and functional regulation
We obtained samples from five different organs (cerebral cortex,
heart, lung, kidney, spleen) and ESC derived from F1 (C57BL/6J x
SPRET/EiJ) hybrid mice, and performed high-throughput RNA-seq
for two biological replicates of each sample to quantify mRNA
expression levels and AS pattern (see the Materials and Methods
section; Fig 1A and Table S1). To cover more cell types, we included
the liver data from the same animals obtained in our previous study
(Gao et al, 2015).
After read mapping (see the Materials and Methods section;
Table S1), we quantified the abundance of different mRNA isoforms,
measured by percent spliced in (PSI) (see the Materials and
Methods section), and estimated the quality of our data (Fig S1). PSI
values derived from total reads (including unambiguously assigned
allelic reads and common reads, see the Materials and Methods
section) were used for examining splicing diversity within single
tissues as well as across tissues. A splicing event was considered as
expressed in a tissue, if aminimumof 20 informative reads (spliced-
in + spliced-out) mapped to the event in both replicate samples
(see the Materials and Methods section). Given that skipped Exon
(SE) events constituted the AS category of the highest abundance
(Table S2), we focused on SE events throughout our analyses. In
total, 15,024 SE events were reliably detected in 6,660 protein-
coding genes (Table S3). Among all SE events, 3,295 (21.9%) were
expressed in only one tissue, 7,732 (51.5%) in two to six, and 3,997
(26.6%) in all the seven tissues (Fig S2A).
We then investigated the patterns of splicing diversity within
individual tissues, in each of which we defined the percent dom-
inant isoform (PDI) of each expressed event as the relative usage of
the dominant isoform in this tissue. Among all tissues, cerebral
cortex showed the highest splicing complexity, with 21.7% of the
expressed genes being alternatively spliced and 5,325 (53.1%)
expressed SE events having PDI values below 0.9 (Fig 1B and Table
S4).
The error hypothesis states that only the dominant isoform of a
gene is functional and predicts that its relative usage is higher for
genes whose mis-splicing would have a large deleterious pheno-
typic impact. Genes with lower expression levels would therefore be
expected to contain more events with lower PDI values than highly
expressed genes. Overall, we observe only a negligible correlation
between the minimum PDI (among all SE events of a gene) and
mRNA expression level, but a weak one when only considering
genes with PDI larger than 0.9 (Fig 1C and Table S5). These events
also show a strong negative correlation between the PDI and the PSI
variation between biological replicates (Table S5). This suggests
that minor splicing isoforms might indeed predominantly reflect
molecular error for events with a PDI above 0.9, whereas the pattern
for the remaining events is less clear.
Previous studies suggest that large splicing changes between
tissues might be functionally important (Wang et al, 2008; Reyes
et al, 2013; Tapial et al, 2017). They could be highly regulated and
affect genes under stronger selective constraints. Our results
substantiate these findings. Events with a switch score (maximum
|ΔPSI| between tissues, see the Materials and Methods section) >
0.5 frequently affect the coding region of a gene, and genes har-
boring these “Switch-Like” events have comparatively high ex-
pression levels, low dN/dS ratios, and high sequence conservation
around the splice sites (Fig S2B–E; see the Materials and Methods
section). Interestingly, we also found an enrichment of micro-exons
in the “Switch-Like” category (Fig S2F), and consistent with previous
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findings (Irimia et al, 2014; Li et al, 2015), these micro-exons often
exhibit the highest inclusion levels in cerebral cortex (Fig 1D).
Together, these results indicate that Switch-Like splicing differ-
ences between tissues are functionally important, especially in the
brain, and result from tissue-specific regulation rather than noisy
RNA processing. In contrast, many of those events with subtle
changes across tissues or slight deviations from a PDI near one
within a tissue may reflect fluctuations in the trans-regulatory
splicing environment.
The effects of cis-regulatory mutations on allelic splicing
divergence are modulated by a scaling law
We then turned to cis-regulatory splicing differences between M.
musculus and M. spretus, using only unambiguously assigned al-
lelic reads (see the Materials and Methods section). Differences
between the two alleles were considered significant if |ΔPSIAS| ≥ 0.1
and the false discovery rate (FDR)-adjusted P-value < 0.05 (see the
Materials and Methods section). As shown in Table S6, the AS
pattern is more conserved between the two alleles in some tissues
(e.g., cerebral cortex and kidney) than in others (e.g., heart and
spleen). This is partially consistent with a previous study which
examined AS patterns in nine tissues from four mammalian species
and chicken, in which the brain also exhibited higher conservation
of splicing patterns (Merkin et al, 2012). As cerebral cortex exhibits
the highest splicing complexity (Table S4), the high conservation of
its splicing pattern indicates the potential functional relevance of
different isoforms more prevalent in this tissue.
We then classified all events expressed in two or more tissues
into three groups (Fig 2A): 1. “All-Divergent”: the 298 events divergent in
all expressing tissues; 2. “Some-Divergent”: the 2,145 events divergent
in some, but not all, of the expressing tissues; 3. “Non-Divergent”: the
4,563 events not divergent in any of the expressing tissues.
Cis-divergence could result from sequence variants in the core
splice sites and/or cis-regulatory elements in the flanking regions.
To investigate the sequence features causing splicing divergence
between the two alleles, we first compared the densities of se-
quence variants, that is, single nucleotide variants (SNVs) and
insertions or deletions, in potential regulatory regions (the alter-
native exon and the 2 × 200 bp flanking intronic regions) between
the three event categories (Fig 2B; see the Materials and Methods
section). As shown in Fig 2B, All-Divergent events have higher
density of variants than Some-Divergent events (mean density:
0.019 versus 0.016, one-sided Wilcoxon rank-sum test P-value =
6.18 × 10−5), which in turn, have higher variant density than Non-
Divergent events (mean density: 0.016 versus 0.015, one-sided
Figure 1. Quantification of alternative splicing
patterns and diversity within and across tissues.
(A) Scheme of experimental design. (B) Proportion of
high percent dominant isoform (PDI) (PDI > 0.9) and low
PDI (PDI ≤ 0.9) SE events within each tissue.
Numbers on the top of bars indicate the number of
events in corresponding categories. (C) Correlation of
PDI of SE event and gene expression of the
corresponding gene in cerebral cortex. (B) Events are
classified into two groups based on PDI values as in (B).
The regression line (red) is fitted with a generalized
additive model. See also Tables S1–S4. (D) 203 micro-
exons exhibit Switch-Like changes between cerebral
cortex and other tissue(s). The percent spliced in
difference between cerebral cortex and other tissues
(cortex–most different tissue) reveals higher inclusion
levels in cerebral cortex than in other tissues. Box
plot elements: center line, median; box limits, lower
and upper quartiles; whiskers, lowest, and highest value
within 1.5 IQR.
Splicing divergence in hybrid mice Zou et al. https://doi.org/10.26508/lsa.202101333 vol 5 | no 4 | e202101333 3 of 14
Wilcoxon rank-sum test P-value = 2.93 × 10−14). Furthermore, we also
surveyed the 39 and 59 splicing sites flanking the alternative exon
and compared the percentage of events with or without variants in
these core splicing sites for the three categories. As shown in Fig 2C,
the splicing sites of All-Divergent events are nearly double as likely
to contain variants as those of Some-Divergent events (38.6%
versus 20.0%, Fisher’s exact test odds ratio = 2.5, P-value = 1.1 × 10−11).
In turn, significantly more Some-Divergent events contain variants
in their splice sites than Non-Divergent events, but the difference is
much less pronounced (20.0% versus 16.2%, Fisher’s exact test odds
ratio = 1.3, P-value = 0.0001; Fig 2C). Furthermore, for those con-
taining variants in splicing sites, allelic differences in splicing
strength of All-Divergent events were significantly higher than
those of Some-Divergent and Non-Divergent events (two-sided K-S
test P-value = 1.033 × 10−8 and P-value = 4.725 × 10−12, respectively; Fig
2D; see the Materials and Methods section). Consistent with this, the
magnitude of allelic PSI differences for All-Divergent is also sig-
nificantly higher than Some-Divergent events (Fig S3A–C). Among
the All-Divergent events, those with a change in splicing site
strength between the two strains had allelic differences of sig-
nificantly higher magnitude than those without (Fig S3D–F). To-
gether, these results indicate that large changes in core splicing
elements are more likely to cause a larger difference in splicing,
leading to significant divergence across all expressing tissues.
The magnitude of splicing divergence between two alleles does
not only depend on the number of mutations affecting cis-regu-
latory elements, but also on the genetic background on which they
occur. As a recently observed “scaling law” suggests, a single cis-
regulatory mutation might lead to a change of greater magnitude
for an event with intermediate inclusion levels (low PDI) than for an
event with high PDI (Baeza-Centurion et al, 2019). To examine a
possible scaling law affecting allelic splicing differences in our
system, we asked whether divergent events with low PDI had larger
differences between the two alleles than those with higher PDI
(choosing the C57BL/6J allele arbitrarily as the reference). This was
indeed the case (Fig 2E), even though events with PSI values above
0.9 or below 0.1 have slightly higher variant densities than events
with intermediate PSI values (Fig 2F). Therefore, the results indicate
that both cis-regulatory sequence variants and a scaling law affect
allelic splicing divergence, and that events with high PDI appear to
tolerate larger numbers of cis-regulatory mutations than those with
low PDI.
AS divergence is larger for genes under relaxed selective
constraint
In general AS events with higher functional impact should be under
stronger selective constraints and therefore more conserved
Figure 2. Cis-regulatory sequence variants and
scaling law affect allelic splicing divergence.
(A) Classification of events expressed in two or more
tissues into three groups based on allelic divergence
across tissues. Numbers on the top of bars denote
the count and percentage of events in corresponding
groups. (B) Distribution of variant density in each
divergence group. Variants in the alternative exon
plus its intronic flanking regions (200 bp on both sides)
were counted and divided by the total length of the
region. Numbers in parentheses denote the numbers
of events in corresponding groups (Two-sided
Wilcoxon rank-sum test). (C) Percentage of SE events
with (steel blue) or without (light sky blue) variants in
splicing sites. Only the 59 and 39 splicing site of the
alternative exon are considered. Numbers on the top of
the bars indicate the total number of events within
the corresponding groups (Fisher’s exact test).
(D) Cumulative distributions of the absolute difference
between predicted scores for splicing site strengths
of C57BL/6J (BL6) and SPRET/EiJ (SPR). Scores of the 59
and 39 splicing sites were summed up for each
alternative exon. (E) Scaling law for allelic splicing
divergence. The average BL6 percent spliced in (PSI)
across tissues is treated as starting PSI, and the |ΔPSI|
(y-axis) between SPR and BL6 is compared between
different ranges of starting PSI (x-axis). Numbers on the
top of boxes indicate the number of events in
corresponding PSI ranges (one-sided Wilcoxon rank-
sum test). (F) Distribution of variant density in
alternative exon and its flanking introns (200 bp on both
sides) for events in different PSI ranges. (E) The 10
bins of PSI are based on the average PSI of the BL6
allele across expressing tissues (starting allele in E).
Boxplots show the Q1 to Q3 quartile values (the box
limits), the median (the horizontal lines), and values
within the 1.5 * IQR (the whiskers). n.s., not significant;
*P < 0.05; **P < 0.01; ***P < 0.001.
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between species. When comparing events with different divergence
patterns across tissues, we found that 90 percent of the Non-
Divergent events affected coding regions of the transcript,
whereas these were only about 85 percent for Some-Divergent
events and 60 percent for All-Divergent ones (Fig 3A). Similarly,
genes with faster protein sequence evolution or lower expression
levels would be expected to exhibit larger splicing divergence than
more conserved or highly expressed genes. To compare selective
constraint and splicing divergence on the gene level, for each gene
containing at least one SE event expressed in two or more tissues,
we calculated a splicing divergence score (SDS; the average per-
centage of tissues with divergent splicing among expressing tissues
of all events in the gene; see the Materials and Methods section).
We divided all genes into three groups according to the SDS: (1) 2,373
Non-divergent genes (SDS = 0); (2) 1,509 genes with “Low Diver-
gence” (SDS < 50); (3) 248 genes with “High Divergence” (SDS ≥ 50).
It turned out that genes with high SDSs had higher average dN/dS
ratios (mouse versus rat) than “Low Divergence” genes (Fig 3B, one-
sided Wilcoxon rank-sum test P-value: 0.0003), followed by non-
divergent genes (Fig 3B, one-sided Wilcoxon rank-sum test P-value:
1.14 × 10−15). “High Divergence” genes also had lower average gene
expression levels than “Low Divergence” genes (Fig 3C, one-sided
Wilcoxon rank-sum test P-value: 0.013) which in turn had lower
average gene expression levels than non-divergent genes (Fig 3C,
one-sided Wilcoxon rank-sum test P-value: 5.56 × 10−5). Similar
patterns can also be observed on the event level (Fig S3G and H)
and in individual tissues (Fig S3I and J).
Intuitively, the higher the gene is expressed, the more the
junction reads it would generate, therefore likely resulting in more
reliable PSI estimates. To check whether the observed lower allelic
divergence in highly expressed genes was not due to sampling bias,
we created a down-sampled dataset in which the number of junction
reads was equal for all the analyzed splicing events in either allele
across all the samples (see the Materials and Methods section). As
shown in Fig S4A–I, the PSI estimates were highly correlated between
the original and down-sampled datasets, and more importantly, the
lower allelic divergence in highly expressed genes could be observed
also based on the down-sampled dataset (Fig S5A).
Interestingly, we also found that Switch-Like events are generally
highly conserved between the two species (Fig S6 and Table S7),
underscoring again their functional importance. Although most cis-
divergent events between the two strains appear to reflect neutral or
near-neutral drift, some might have a significant effect on the or-
ganismic phenotype. We found five candidate events affecting coding
regions with substantial allelic divergence and high expression levels
(see the Materials and Methods section), and therefore potential
functional impact (Fig S7A–E). We were also able to identify several
potential cis-regulatory changes which might cause the large diver-
gence between the two alleles for two of these events (Fig S7A and B).
Tissue-dependent patterns in AS divergence reveal buffering
in trans
The biological effect of cis-regulatory differences between alleles
depends on the trans-regulatory environment of each tissue. In-
terestingly, among the “Some-Divergent” events, gene expression
levels were higher in non-divergent than in divergent tissues (Fig
4A). And for most events the magnitude of the allelic splicing
difference showed a negative correlation with mRNA expression
level across tissues (Fig 4B), indicating that mutations affecting
Figure 3. Genes under relaxed selective constraints
exhibit more divergence in alternative splicing.
(A) Proportion of coding (steel blue) and non-coding
(light sky blue) alternative exons in the three divergence
groups. The percentage of coding alternative exons
in each group is indicated within the corresponding
bar, and numbers on the top of bars denote total
numbers of events in the corresponding groups.
(B) Comparison of dN/dS ratios of genes belonging to
different divergence groups (indicated by different
colors) based on splicing divergence score score (see
the Materials and Methods section). Numbers in
parentheses indicate the number of genes within
corresponding groups (one-sided Wilcoxon rank-
sum test). (C) Comparison of average gene expression
level among the three divergence groups. Numbers in
parentheses indicate the number of genes within
corresponding groups (one-sided Wilcoxon rank-sum
test).
Splicing divergence in hybrid mice Zou et al. https://doi.org/10.26508/lsa.202101333 vol 5 | no 4 | e202101333 5 of 14
splicing accuracy might be buffered in tissues where the gene is of
more functional importance. Importantly, such phenomena could
again be observed based on our down-sampled dataset, excluding
the possibility that the observation is due to sampling bias (Fig S5B
and C). Interestingly, we also found a negative correlation between
gene expression level and ΔPSI between biological replicates
across all the tissues, based on both original and down-sampled
dataset (see the Materials and Methods section; Fig S8), indicating
increased splicing noise for lowly expressed genes and further
supporting our buffering hypothesis.
Patterns of allelic splicing divergence across tissues can be
assigned to four different scenarios (Fig 5A): (1) both alleles exhibit
tissue-dependent splicing, but the direction of change differs
between alleles, (2) both alleles are spliced in a tissue-dependent
manner with identical tissue-dependent isoform-preference, (3)
tissue-dependent splicing occurs in only one allele whereas the
other one shows no difference between tissues, (4) both alleles lack
tissue-dependent splicing, but isoform usage is consistently di-
vergent across tissues. To distinguish among these scenarios, for each
event expressed in two or more tissues and divergent in at least one
tissue, we compared the allelic ΔPSIT (PSIT1 − PSIT2) in the tissue pair
with the largest ΔΔPSI (|ΔPSIAllelic_T1 − ΔPSIAllelic_T2|; see the Materials
andMethods section; Fig 5B).We considered an eventwithΔPSIT higher
than 0.1 as differentially spliced between tissues. Of the 2,443 events,
only 85 (3.5%) events exhibited opposite signs of ΔPSIT in the two
tissues, fitting scenario 1. This shows that cis-divergence causing
opposite allelic changes between tissues is rare, similar to the pre-
viously observed patterns for alternative polyadenylation (Li et al,
2020). Among the remaining events, 247 fit scenario 2 with parallel
changes in isoform abundance between tissues and 456 fit scenario 4
with equal divergence across tissues, whereas the majority (1,655,
67.7%) fit scenario 3 with only one allele showing tissue-dependent
splicing. The much higher frequency for scenario 3 in comparison to
scenario 1 and 2 remained almost the same if different cutoffs (ranging
from 0.1 to 0.2) were applied to determine differential splicing between
tissues (see the Materials and Methods section; Table S8 and Fig S9).
We then compared the tissue-dependent regulation of the
(more) variable allele between scenario 2 and scenario 3. Inter-
estingly, as shown in Fig 5C, the maximum tissue difference is
significantly higher in scenario 2, compared to scenario 3 (median
value 0.45 versus 0.17, Wilcoxon rank-sum test, P < 2.2 × 10−16; Fig 5C).
This indicates that on one hand scenario 2 consists of more events
with functional tissue-dependent regulation. On the other hand, for
events in scenario 3, the allele with tissue-dependent splicing may
be under noisy regulation. If this is true, we would expect that in
scenario 3 the variable allele is less conserved. In contrast, if the
allele with tissue-dependent splicing reflects functionally impor-
tant regulation, that allele should show a more conserved pattern.
To distinguish this, we took advantage of a published RNA-seq
dataset (Thybert et al, 2018) for whole brain, liver, kidney, and heart
from the closely related out-group species Mus caroli (Ryukyu
mouse) and Mus pahari (Gairdner’s shrewmouse). We considered all
events expressed in at least two of the four tissues with out-group
data and divergent in at least one of them, and classified them into
the scenarios as described above (with the difference that we only
consider the tissue pair with the largest ΔΔPSI among these four
tissues and not all seven). In total, 826 events in the selected tissue
pairs fit scenario 3 (Fig S10A). We compared their splicing patterns in
the two tissues with their orthologous events in the respective tis-
sues of the two out-group species (see the Materials and Methods
section; Fig S10B). 170 events have orthologous events in at least one
of the two out-groups, and indeed, among them the variable allele is
less likely to exhibit the tissue-dependent splicing pattern conserved
with the out-group species than the stable allele (23.5% versus 44.1%;
Table S9). For these events with non-conserved variable allele, the
observed tissue-dependent splicing might represent increased
molecular error due to a lack of trans-regulatory buffering in the
tissue where accurate isoform choice is less important.
When comparing micro-exons to larger exons, we found that
micro-exons showing allelic divergence are enriched in scenario 2
(Fig 5D), and that the difference between scenario 2 and scenario 3
in the magnitude of tissue-dependent change is even higher for
micro-exons (median value of ΔPSIT 0.62 versus 0.19, Wilcoxon rank-
sum test, P = 9.9 × 10−13; Fig S10C) than for all exons as a whole (Fig
5C), again indicating the functional importance of tissue-
dependent regulation in this exon class.
Perturbation of the splicing machinery unmasks non-adaptive
cis-regulatory changes
As mentioned above, for Some-Divergent events, in tissues where
accurate splicing of a gene is important, both alleles often showed
Figure 4. Negative correlation between gene
expression and splicing divergence.
(A) Comparison of average gene expression level of
genes with “Some-Divergent” events in divergent tissues
versus non-divergent tissues, the number in
parentheses is the number of “Some-Divergent” events
(One-sided Wilcoxon signed-rank test). (B) Distribution
of Spearman’s correlation coefficients between
|ΔPSI| and gene expression across tissues for events
expressed in ≥3 tissues and divergent in ≥1 tissue(s)
(one-sided Wilcoxon signed-rank test). Box plot
elements: center line, median; box limits, lower and
upper quartiles; whiskers, lowest and highest value
within 1.5 IQR. n.s., not significant; *P < 0.05; **P < 0.01;
***P < 0.001.
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conserved splicing patterns, even if mutations might have led to
weaker cis-regulatory signals in one allele. We therefore hypoth-
esized that in these “important” tissues, relevant trans-regulators,
when expressed at high levels, could buffer against potentially
deleterious cis-regulatory changes. In contrast, in tissues, where
these splicing regulators are expressed at low levels, the pheno-
typic effects of cis-regulatory mutations would become visible.
To examine such buffering effect, instead of individual tissue-
specific splicing regulators, which would only affect a limited
number of events and therefore would not validate our buffering
hypothesis in a statistically meaningful manner, we chose to
perturb the general splicing machinery and then compared the
allelic splicing pattern in our F1 system. More specifically, we
treated a fibroblast cell line, previously derived from the same F1
hybrid mice (Gao et al, 2015), with pladienolide B, a macrocyclic
lactone that inhibits mRNA splicing by selectively binding to the
splicing factor 3B (SF3B) (Kotake et al, 2007; Yokoi et al, 2011), a key
component of the spliceosomal U2 snRNP complex (Gozani et al,
1998). We expected that pladienolide B treatment of our F1 fibro-
blasts would result in a decrease in splicing accuracy and therefore
unmask many of the previously unobserved cis-divergences.
We determined mRNA levels and splicing patterns similarly as
those in F1 hybrid tissues (see the Materials and Methods section).
Consistent with previous publications (Yoshimoto et al, 2017; Wu
et al, 2018), pladienolide B treatment led to an increase in exon
skipping and intron retention (Fig 6A). Given the focus of all our
analyses on SE events, we considered the 3,583 SE events detected
in both pladienolide B–treated and control (DMSO treated) sam-
ples. As shown in Fig 6B, both the percentage of allelic divergent
events and the average magnitude of divergence increased dra-
matically after pladienolide B treatment (Fig 6B). Whereas 195 (5.4%)
events were divergent only in the control sample, 670 (18.7%) were
so in the treatment sample. This difference became even larger if
we only considered highly divergent events (with |ΔPSI| ≥ 0.2): 295
(8.2%) events are highly divergent only in pladienolide B–treated
cells, whereas 63 (1.8%) are highly divergent only in the control
Figure 5. Patterns of tissue-dependent allelic
splicing divergence.
(A) Scheme illustrating the four scenarios. Each
segment indicates the pattern of splicing change of one
allele between tissues and the two alleles are
indicated with two different colors. (B) Allele-specific
tissue-regulatory patterns. The x-axis presents the
percent spliced in (PSI) difference of the C57BL/6J
(BL6) allele between the two tissues with maximal
difference in allelic ΔPSI, and the y-axis presents the
corresponding information for the SPRET/EiJ (SPR)
allele. (C) Scenario 2 holds higher PSI difference
between tissues than Scenario 3. The maximum
between-tissue PSI differences of the two alleles are
compared among the four scenarios. Median value of
the ΔPSIT in each scenario is indicated in the box, and
numbers in parentheses represent the numbers of
events belonging to the corresponding scenarios. One-
sided Wilcoxon rank-sum test was used to test for
significance. (D) Micro-exons are enriched in
Scenario 2 and less likely to be in Scenario 3 or 4. The
bar plot shows the percentage of each scenario
compared between micro-exons (dark orange) and
other exons (forest green). Fisher’s exact test was used
to test for significance. n.s., not significant; *P < 0.05;
**P < 0.01; ***P < 0.001.
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sample. We obtained similar results when using the fold change in
splicing efficiency due to cis-mutations, that is, the additive effect
“A” as described before (Baeza-Centurion et al, 2019; Baeza-
Centurion et al, 2020), instead of ΔPSI as a measure of splicing
divergence (see the Materials and Methods section; Fig S11).
We then examined the potentially unmasked events after pla-
dienolide B treatment, that is, those non-divergent in control fi-
broblasts but divergent after treatment. Among 670 events, 206
were also expressed in at least one of the seven tissues we in-
vestigated. As shown in Fig 6C, these events showed significantly
higher allelic difference in the expressing F1 tissues than those that
remain non-divergent after treatment. Importantly, for these
events, the direction of divergence unmasked after treatment is
largely consistent with that observed in the divergent tissues, in-
dicating that the same cis-regulatory variants are contributing to
the splicing differences observed after splicing perturbation. Fur-
thermore, we looked from the other side and examined how dif-
ferent events categorized based on allelic data from the seven
tissues responded to the pladienolide B treatment. As shown in Fig
6D, after perturbation, the divergent events defined based on the F1
Figure 6. Many previously buffered non-adaptive cis-regulatory changes are unmasked by perturbation of the splicing machinery.
(A) Incidence of Retained Introns (RI) and Skipped Exons (SE) increased after pladienolide B (0.1 μM) treatment (one-sided Wilcoxon signed-rank test). (B) Increase in
allelic splicing divergence after pladienolide B treatment. x-axis and y-axis are percent spliced in (PSI) divergence between the two alleles in the DMSO treated sample
and the pladienolide B–treated sample, respectively. Events are classified into different groups based on PSI divergence in the two samples. The count of events in each
group is indicated by numbers in parentheses. (C) Patterns of PSI divergence after pladienolide B treatment are consistent with those in other F1 tissues. Events were
classified into different groups based on allelic splicing divergence after pladienolide B treatment, and the maximal ΔPSI between alleles in F1 tissues are compared for
the above groups. (D) Divergent events in F1 tissues are also more likely divergent after pladienolide B treatment and with consistent direction. Events were classified into
three groups based on the divergence pattern in F1 tissues, and the ΔPSI (BL6-SPR) values were compared between pladienolide B–treated samples and DMSO-treated
samples. Outliers in each group are hidden and the y-axis has been limited to −0.35 to 0.35. One-sided Wilcoxon signed-rank test was used to test difference from zero for
median values within each group, whereas one-sided Wilcoxon rank-sum test was used for comparing between groups. Box plot elements: center line, median; box limits,
lower and upper quartiles; whiskers, lowest and highest value within 1.5 IQR. n.s., not significant; *P < 0.05; **P < 0.01; ***P < 0.001.
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tissue data showed higher magnitude of change in their allelic
divergence than the non-divergent ones and again the allelic
difference after treatment generally was in the same direction as
the divergence observed in the F1 tissues. This further corroborated
that under non-optimal splicing regulation, the cis-regulatory
variants would result in higher allelic splicing divergence.
Discussion
Our comprehensive analysis of allelic AS patterns in an interspecific
mouse hybrid reveals that cis-regulatory divergence between the
two strainsmainly affects genes under relaxed selective constraints
as predicted by the neutral theory of molecular evolution. Inter-
estingly, for the same gene, expression levels also are generally
higher in tissues in which its splicing pattern is conserved than in
divergent tissues (Fig 3D). In 69.2% of these tissue-dependent di-
vergent events, one allele exhibits no significant PSI differences
between tissues (“stable” allele), but the other does (“variable”
allele). The former more often represents the ancestral splicing
pattern, based on the comparison with two out-group species.
These findings support the hypothesis that in most cases the
derived splicing pattern is the result of neutral or slightly dele-
terious cis-regulatory mutations, whose effects are masked in
tissues where accurate splicing is essential. Therefore, it indicates
that trans-regulatory factors are capable of buffering cis-regulatory
mutations in tissues where they are highly abundant, ensuring
accurate splicing of events even with “weaker” cis-regulation (e.g.,
the allele with reduced RBP binding affinity) and therefore acting as
“buffers” or “phenotypic capacitors” (Rutherford & Lindquist, 1998).
To test this hypothesis, we chose to chemically inhibit the splicing
factor 3b (SF3B) with pladienolide B in our F1 hybrid fibroblasts
because we assume that many auxiliary trans-regulators exert their
effects through core components of the splicing machinery, for
example, by increasing or decreasing the association of the splicing
machinery to specific exon/intron junctions. Therefore, modest
perturbation of core components might mimic that of auxiliary
factors with tissue-dependent expression. As predicted, the per-
centage of divergent events and the average magnitude of splicing
divergence between the two alleles both increased after treatment,
suggesting that in many cases one allele with weak cis-regulatory
elements is more susceptible to splicing error after this kind of
perturbation and that larger error means larger deviation from an
optimal splicing pattern common to both alleles. This is further
supported by the finding that divergence after treatment increased
in the same direction as found in the tissues where the event
exhibits a cis-regulatory difference between the two alleles and
that the change in allelic divergence is larger for the events showing
higher allelic difference across tissues. The observed buffering
could explain the genetic phenomenon where splicing mutations
have incomplete penetrance or tissue-specific phenotypes (Scotti
& Swanson, 2016), as their effects might depend on the genetic
background of an organism, its physiological state, cell type, so-
matic mutations and the resulting trans-regulatory environment
(Braunschweig et al, 2013). Whether the phenotypic capacitance
observed in this study also leads to a significant potential for
adaptive evolution as suggested by theoretical considerations and
simulations (Masel, 2006), or whether cis-regulatory variants,
whose effects are masked under normal circumstances, lead to an
increased risk for cancer or degenerative diseases (Park et al, 2018),
deserves further investigation. It will also be important to under-
stand how the expression of trans factors in different tissues is
coordinated with that of their target genes and with epigenetic
modifications to ensure accurate splicing of essential genes in a
tissue.
Besides trans-regulatory buffering, we also find that events with
very high PDI values can tolerate a larger number of cis-regulatory
mutations without showing changes in splicing patterns. This
scaling law has previously been experimentally tested and
mathematically described (Baeza-Centurion et al, 2019) and might
contribute to the robustness of splicing events with only one
optimal isoform. Indeed, as shown in Fig S12A, the non-differential
events with PDI values above 0.9 show high sequence conservation
in the alternative exon, but paradoxically the lowest sequence
conservation in the intronic flanking region. In contrast, for those
Switch-Like events, where both isoforms are functionally important,
cis-regulatory regions experience much stronger selective con-
straint and therefore exhibit higher conservation in both exon and
intronic flanking regions (Figs S2E and S12A). It turned out that most
non-differential events have a very high PDI, whereas the Switch-
Like events are composed of those with lower PDI (Fig S12B).
Therefore, whereas for both categories the exons consist of se-
quences of functional importance, and therefore are highly con-
served, only Switch-Like events exhibit high conservation in
intronic regions flanking splicing sites because the non-differential
events with high PDI are comparatively robust to cis-regulatory
perturbations. In the same manner, because they are also insen-
sitive to the fluctuation of trans-regulatory environments, these
events show hardly any changes in their splicing pattern across
tissues. Therefore, for the events with only one optimal isoform, the
robustness of their splicing pattern is largely hardwired.
Across tissues, on one hand, brain showed low allelic divergence
(Fig S12C). In particular, only 7.5% of events expressed in brain and
one other tissue exhibited divergence in brain, but no divergence in
the other tissue. This percentage is the lowest among all the seven
tissues, suggesting that the trans-regulatory splicing environment
is most efficient in brain (Fig S12C). It also expressed the highest
diversity of splicing isoforms, that is, more than half of the AS events
were of PDI < 90%. Likely, both isoforms would be functional.
However, given these events would be more sensitive to fluctua-
tions of the trans-regulatory environment, the high splicing effi-
ciency in brain is essential to ensure the stable/correct isoform
compositions. This may explain why some splicing regulators are
specific to or found in higher abundance in the nervous system (Raj
& Blencowe, 2015; Vuong et al, 2016) and why neurological defects
are often the most prominent symptoms of patients with mutations
in splicing regulators (Singh & Cooper, 2012; Chen et al, 2019).
Although our results show that most of the divergence between
closely related mammalian species fits the neutral model and that
cis-regulatory mutations are frequently buffered in tissues where
accurate splicing is important, we find five examples of splicing
differences with a potential functional impact. Although it is
possible that these divergent events are the result of slightly
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deleterious mutations, especially for those found only in laboratory-
derived mouse strains, some might also contribute to species- or
strain-specific adaptations. It would be interesting to further
examine in future studies whether the inclusion levels of any of




Female F1 hybrid mice (female C57BL/6J x male SPRET/EiJ) used for
tissue isolation were obtained as described before (Gao et al, 2013).
All mice were kept in an air-conditioned, temperature-controlled
conventional animal house and obtained standard chow and water
ad libitum. Mice were euthanized at the age of 8 wk, and tissue
samples from five organs (cerebral cortex, spleen, kidney, heart,
and lung) were harvested as described before from two animals
(Gao et al, 2015). ESC and fibroblasts were derived from the F1 hybrid
mice. Two independent ESC clones were used in this study. For
perturbing the splicing machinery, pladienolide B (#16538; Cayman)
was prepared in DMSO at 0.1 mM, and used to treat fibroblasts at
0.1 μM for 4 h. Control fibroblasts were treated with 0.1% DMSO for
4 h. All animal husbandry and experiments were approved by the
local ethical committee (VIB and Ghent University).
Total RNA was extracted using TriZOL reagent (Life Technologies)
following the manufacturer’s protocol. Then, stranded mRNA se-
quencing libraries were prepared with 500 ng total RNA. All samples
were sequenced on a HiSeq 2000/2500 (Illumina) sequencer.
Samples from heart, kidney and cerebral cortex were sequenced
with paired-end reads of 101 bp in length. Samples from spleen,
lung and ESC were sequenced with paired-end reads of 76 bp in
length. The sequencing depth for each biological replicate was
240~260 million reads per sample, except for the two ESC samples,
for which we obtained 175 million and 202 million reads, respec-
tively (Table S1). Data for liver were obtained from Gao et al (2015).
Public RNA-seq data for human (human body map 2.0)
Pan-tissue RNA-seq raw data of human were downloaded from
the ArrayExpress database with accession number E-MTAB-513.
The raw data were mapped using STAR (version 2.7.1a) with pa-
rameters “—runThread 40 –outSAMtype BAM SortedByCoordinate
–alignEndsType EndToEnd.”
Reference genome and gene annotation
The referenceM. musculus genome (mm10) and gene annotation of the
C57BL/6J strain were downloaded from the Ensemble database (ftp://
ftp.ensembl.org, version: GRCm38, release 74). SNVs and insertions/
deletions (indels) between C57BL/6J and SPRET/EiJ were downloaded
from the Mouse Genome Project (http://www.sanger.ac.uk/).
The vcf2diploid tool (version 0.2.6) in the AlleleSeq pipeline
(Rozowsky et al, 2011) was used to construct the SPRET/EiJ genome
by incorporating the SNVs and indels into the C57BL/6J genome. The
chain file between the two genomeswas also reported as an output,
which was further used with g2gtools to convert SPRET/EiJ coor-
dinates to C57BL/6J coordinates.
Mapping and allele-specific read assignment
To ensure that RNA-seq reads from all the samples have the same
length, we trimmed 25 bp from the 39 end of the 101 bp reads. We
aligned the RNA-seq reads to the C57BL/6J reference genome and
SPRET/EiJ genome separately with HISAT2 (Kim et al, 2015) (version
2.0.1) with parameters -p 12 -k 2 –reorder –no-softclip. Reads were
assigned to the genome with less mapping edit distance. The reads
with equal mapping distance to both genomes were designated as
common reads. Genomic alignment coordinates of the reads that
were assigned to SPRET/EiJ were then converted to the corre-
sponding locations in the C57BL/6J reference genome using the
g2gtools software (version 0.1.29).
Known imprinted genes deposited in the Geneimprint database
(http://www.geneimprint.com/site/genes-by-species) and genes
on the sex chromosomes or mitochondria were excluded from all
analyses.
AS analysis
The “replicate Multivariate Analysis of Transcript Splicing” (rMATS)
(Shen et al, 2014) software was used with the default parameters for
quantification and comparison of AS. The rMATS software counts
the numbers of reads and the effective lengths of the inclusion
isoform and the exclusion isoform (the number of unique isoform-
specific read positions) to estimate the PSI value, representing the
proportion of the inclusion isoform. For an event to be counted as
“expressed” we required a minimum of 20 total reads (spliced-in +
spliced-out) in each replicate sample when quantifying total
splicing level (without distinguishing alleles) or in each allele when
quantifying allelic splicing level. Events with PSI values in all
expressing tissues either higher than 0.9 or lower than 0.1 in both
replicates were not considered as alternatively spliced and
therefore filtered out in the analyses based on total reads. For
analyses of allelic splicing patterns, these events were only filtered
if these conditions were also met by both alleles considered
separately. We defined the PDI as PDI = |PSI − 0.5| + 0.5.
Allelic AS analysis
Only the reads that could be unambiguously assigned to either
genome were retained for estimating allele-specific AS in the F1
hybrid. Therefore, estimated allelic PSI and ΔPSI values might be
inaccurate for events with lower SNP density. To avoid this potential
error, using rMATs, we calculated and compared PSI values based
on (1) the union of unambiguously assigned C57BL/6J reads and
SPRET/EiJ reads only and (2) the union of C57BL/6J reads, SPRET/EiJ
reads and common reads. Only the events for which the PSI values
were consistent between the two datasets (ΔPSIconsistency ≤ 0.1 and
FDR > 0.5) were retained for allelic analyses.
The allele-specific difference in inclusion levels (ΔPSIAllelic) for
each event and each tissue was calculated as the difference
between the average C57BL/6J inclusion level and the average
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SPRET/EiJ inclusion level from the two biological repeats
(ΔPSIAllelic = PSIC57BL/6J − PSISPRET/EiJ). A hierarchical model to si-
multaneously account for sampling uncertainty in individual rep-
licates and variability among replicates was used in rMATS as a
measure of statistical significance for PSI differences. A combined
threshold of FDR < 0.05 and average |ΔPSIAllelic| ≥ 0.1 was used to
define divergent events between two alleles in each tissue/cell line.
We defined ΔΔPSI as the difference in allelic splicing divergence
between two tissues (ΔΔPSI = |ΔPSIAllelic_T1 − ΔPSIAllelic_T2).
Definition of four scenarios of tissue-dependent allelic
splicing divergence
Events expressed in two or more tissues and divergent in at least
one tissue were classified into four different scenarios according to
their allelic splicing patterns across tissues: (1) both alleles exhibit
tissue-dependent splicing, but the direction of change differs
between alleles, (2) both alleles are spliced in a tissue-dependent
manner with identical tissue-dependent isoform-preference, (3)
tissue-dependent splicing occurs in only one allele whereas the
other one shows no difference between tissues, and (4) both alleles
lack tissue-dependent splicing, but isoform usage is consistently
divergent across tissues. To distinguish among these scenarios, we
compared the allelic ΔPSIT (PSIT1 − PSIT2) in the tissue pair with the
largest ΔΔPSI (|ΔPSIAllelic_T1 − ΔPSIAllelic_T2|). If ΔPSIT of both alleles is
greater than the cutoff but with opposite direction, events are
assigned to scenario 1; if ΔPSIT of both alleles is greater than the
cutoff and in the same direction, then events are assigned to
scenario 2; if only ΔPSIT of one allele is greater than the cutoff, these
events are assigned to scenario 3; the remaining events are
assigned to scenario 4, in which ΔPSIT of both alleles is less than the
cutoff. We repeated our classification with different cutoffs ranging
from 0.1 to 0.2.
Down-sampled dataset
To examine whether our estimates of allelic splicing divergence are
biased because of sampling error, we down-sampled the assigned
reads to the same level in either allele across all samples. Briefly,
for each event of each allele in each sample, we randomly picked 20
reads from all junction reads supporting this splicing event, and
calculated a PSI value measuring the inclusion level of the alter-
native exon based on these 20 reads. For total splicing level
(without distinguishing between alleles), we also performed an
analogous down-sampling analysis. For each event, we randomly
picked 20 reads from all junction reads (including allelic reads and
common reads) for each event, and calculated a PSI value based on
these 20 reads.
Calculation of switch score
To compare the AS patterns across tissues, we defined the “switch
score” as the maximum pairwise absolute PSI difference (|ΔPSIT|)
between expressing tissues, a measure also used in a previous
study (Wang et al, 2008). Based on the switch score, events were
classified into five groups: (1) “Non-Differential” with a switch score
< 0.1; (2) “Low” with 0.1 ≤ switch score < 0.2; (3) “Moderate-Low”
when the switch score was in the range of [0.2, 0.3); (4)
“Moderate-High” for events with switch scores in the range of
[0.3, 0.5); (5) “Switch-Like” in the case of events with switch
scores ≥0.5.
Gene expression analysis
FeatureCounts (Liao et al, 2014) was first used to calculate the
number of reads properly mapped to each gene in each tissue
with parameters “-p -a $gtf -O -s 2 -t exon -g gene_id -T 36 –B
–fraction.” Fragments were counted once if they overlapped
with multiple exons within the same gene. Fragments over-
lapping with more than one gene were assigned a fractional
count to each overlapping gene (each overlapping gene re-
ceives a count of 1/y from a read, where y is the total number of
genes overlapping with the read). Transcripts per kilobase per
million mapped reads (TPM) were used to quantify gene ex-
pression levels.
Splicing site strength score analysis
For each splicing event, nine nucleotides from position −3 through
six of the 59 splice site and 15 nucleotides from position −14 through
1 of the 39 splice site of alternative exons were extracted from the
C57BL/6J and SPRET/EiJ genomes. These sequences were uploaded
to the “Analyzer Splice Tool” server (http://host-ibis2.tau.ac.il/
ssat/SpliceSiteFrame.htm) to calculate the splicing site strength
score.
Estimation of sequence conservation and variant densities
PhastCons scores of the Euarchontoglires clade (comprising ro-
dents, rabbits, primates, and related species) were used to estimate
sequence conservation. The pre-calculated PhastCons score data
were obtained from the UCSC genome browser through the link: https://
hgdownload.cse.ucsc.edu/goldenpath/mm10/phastCons60way/. Sequence
variant density in selected regions (alternative exon plus 200 bp
intronic flanking region on each side) was calculated based on
SNVs and indels between C57BL/6J and SPRET/EiJ, one indel being
counted once irrespective of its length.
Potential effects of AS events and measurements of
selective constraint
The coding sequence (CDS) annotation of each exon in the M.
musculus mm10 genome was downloaded from the Ensembl da-
tabase (release 75) via the BioMart interface. An event was defined
to affect a coding region if the alternatively spliced region in this
event overlaps with the coding sequence according to the CDS
annotation.
To estimate selective constraints on the amino acid sequences
of proteins, we used dN/dS ratios (ratio of the number of non-
synonymous substitutions per nonsynonymous site to the number
of synonymous substitutions per synonymous site) (Miyata &
Yasunaga, 1980) between the house mouse (M. musculus) and
rat (Rattus norvegicus) downloaded from the ENSEMBL database
(ensembl.org).
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Analysis of RNA-seq data from M. caroli and M. pahari
RNA-seq data of whole brain, heart, kidney, and liver produced in a
previous study (Thybert et al, 2018) were downloaded from the
European Nucleotide Archive (ENA, Study accession: PRJEB20980).
Two biological replicates are available for each of the four tissues for
M. caroli and one sample is available for each tissue for M. pahari.
The raw reads were aligned to the M. caroli reference genome
(version 1.1) and M. pahari reference genome (version 1.1), respectively,
by using HISAT2 (version 2.1.0) with similar parameters as used for
aligning sequencing data from our F1 tissues (and with the additional
parameters “--trim3 10 –trim5 5”). The rMATS software (version 4.0.2) was
used for the detection and quantification of AS events in each dataset.
Calculation of adjusted ΔPSI between replicates
The adjusted ΔPSI between replicates is defined for each event as the
PSI difference between two replicates subtracting the PSI difference of
each event between two mocked replicates. To generate two mocked
replicates, for each event, we first combined reads supporting the
inclusion isoform and reads supporting the exclusion isoform, keeping
their label, and then randomly split them into two sets as two mocked
replicates based on the original read numbers in replicate 1 and
replicate 2. PSI values were calculated based on labeled reads in each
mocked replicate using the rMATS model. This process was repeated
100 times and the |ΔPSI|mock calculated as the average |ΔPSI| between
mocked replicates. Finally, the adjusted |ΔPSI| can be calculated by
subtracting |ΔPSI|mock from |ΔPSI| between the two original replicates.
The calculation processes were completed with in-house R scripts.
Calculation of SDS
To measure splicing divergence at the gene level, we defined the
SDS as the average percentage of tissues with divergent splicing
pattern among all expressing tissues of all events in the gene. More
specifically, for all genes containing n events expressed in at least






where di represents the number of tissues in which the AS event i is
divergent, and ei means the number of tissues in which the splicing
event i is expressed.
Genes are classified into three groups based on their SDS scores: the
“Non-Divergent” group contains genes with SDS = 0, “Low Divergence”
are geneswith SDS < 50, and “HighDivergence”are geneswith SDS ≥ 50.
Identification of orthologous events in out-group species
To identify orthologous events in the two out-group species (M.
caroli and M. pahari) for selected events, the orthologous genes of
the events were identified first according to the annotation in the
gene transfer format files of the corresponding species down-
loaded from Ensembl. Then every exon in the orthologous gene was
compared with the exons in the selected events, and only an
exon with the same size and more than 90% sequence identity
was treated as an orthologous exon. For an event to be considered
orthologous, all the three relevant exons need to have orthologous
exons in the same order as in C57BL/6J.
Identification of ancestral and derived allelic splicing patterns
For events with allelic divergence and with ortholog(s) in at least
one of the two out-group species (M. caroli and M. pahari), the
C57BL/6J and the SPRET/EiJ allele were categorized as either de-
rived or conserved in the following way (Fig S10B).
For each tissue, we calculated the average PSI value of the
C57BL/6J and the SPRET/EiJ allele. If the PSI value of the ortholo-
gous event in the corresponding tissue of the out-group (cerebral
cortex in our data was compared with whole brain in the out-group
species) is within the range PSIavg ± 0.05 it was classified as “in-
termediate.” Otherwise, it was classified as either C57BL/6J-like or
SPRET/EiJ-like, depending on which allelic PSI value is closer. If only
one out-group was available, being either C57BL/6J-like or SPRET/
EiJ-like, or both out-group values were consistently classified as
similar as to the same allele, this allele was designated as “con-
served” and the other one as “derived.” If the classification of the
two out-groups was inconsistent (one C57BL/6J-like and one
SPRET/EiJ-like) or both were classified as “intermediate,” the
conservation pattern was considered ambiguous in this tissue.
To determine the overall conservation pattern, we compared the
tissue pair with the largest difference in ΔΔPSI among the four
tissues with out-group data. If the same allele was classified as
“conserved” (with ancestral splicing pattern) in both tissues, we
used this classification for our analysis. If the two tissues showed
opposite conservation patterns (in one tissue the C57BL/6J allele
was classified as conserved and in the other tissue the SPRET/EiJ
allele), the event was excluded. If both tissues were classified as
“ambiguous,” the overall conservation pattern was considered
“ambiguous.” In the remaining cases (one tissue with ambiguous
and one with unambiguous conservation pattern), we determined
the pattern based on the tissue with the larger magnitude of di-
vergence between the C57BL/6J and the SPRET/EiJ allele.
Identification of candidates of divergent splicing with potential
functional relevance
Splicing events largely divergent between species may have
functional impact on organismal phenotype if they occur on highly
conserved exons and within highly expressed genes. To search for
such kind of splicing events, we identified all candidate events with
|ΔPSI| ≥ 0.5 in at least one tissue, and an expression level in the
divergent tissue(s) no less than 30 (TPM). In addition, the maximal
expression level of the gene in tissues with large divergence had to
be equal to or higher than the average expression level of this gene
across expressing tissues. Finally, alternative exon of the event is
highly conserved (mean PhastCons score ≥ 0.8).
Calculating the fold change of splicing efficiency between alleles
We also calculated fold change of splicing efficiency to measure
splicing divergence (additive effects, “A”) as used by Baeza-Centurion
et al (2019) and Baeza-Centurion et al (2020). By taking one allele
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(allele with the lower PSI) as starting allele, an “A” score was
calculated according to the following equation:
A = PSI
2
s − 100 × PSIs + ΔPSI × PSIs − 100 × ΔPSI
PSIsðΔPSI + PSIs − 100Þ ;
where PSIs represents the starting PSI; ΔPSI denotes the PSI dif-
ference between the two alleles.
Data Availability
Raw and transformed data are available from the Gene Expression
Omnibus (accession GSE154727).
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
202101333.
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